199 related articles for article (PubMed ID: 10591480)
1. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats.
Kosasa T; Kuriya Y; Yamanishi Y
Jpn J Pharmacol; 1999 Oct; 81(2):216-22. PubMed ID: 10591480
[TBL] [Abstract][Full Text] [Related]
2. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Eur J Pharmacol; 2001 Mar; 415(2-3):157-64. PubMed ID: 11274994
[TBL] [Abstract][Full Text] [Related]
5. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
Dronfield S; Egan K; Marsden CA; Green AR
J Psychopharmacol; 2000; 14(3):275-9. PubMed ID: 11106308
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of TAK-147 (zanapezil) and E-2020 (donepezil) on extracellular acetylcholine level and blood flow in the ventral hippocampus of freely moving rats.
Hatip-Al-Khatib I; Takashi A; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2004 Jun; 1012(1-2):169-76. PubMed ID: 15158174
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 1999 Dec; 386(1):7-13. PubMed ID: 10611458
[TBL] [Abstract][Full Text] [Related]
9. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
Zhao Q; Tang XC
Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.
Hatip-Al-Khatib I; Iwasaki K; Yoshimitsu Y; Arai T; Egashira N; Mishima K; Ikeda T; Fujiwara M
Br J Pharmacol; 2005 Aug; 145(8):1035-44. PubMed ID: 15951830
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):609-13. PubMed ID: 11256231
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
13. Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain.
Isoma K; Ishikawa M; Ohta M; Ogawa Y; Hasegawa H; Kohda T; Kamei J
Jpn J Pharmacol; 2002 Feb; 88(2):206-12. PubMed ID: 11928722
[TBL] [Abstract][Full Text] [Related]
14. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
15. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.
Giacobini E; Zhu X D; Williams E; Sherman KA
Neuropharmacology; 1996 Feb; 35(2):205-11. PubMed ID: 8734490
[TBL] [Abstract][Full Text] [Related]
16. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
[TBL] [Abstract][Full Text] [Related]
17. Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.
Grasing K; Yang Y; He S
Behav Pharmacol; 2011 Feb; 22(1):58-70. PubMed ID: 22173266
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Jann MW; Shirley KL; Small GW
Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
[TBL] [Abstract][Full Text] [Related]
20. Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats.
Kawashima K; Sato A; Yoshizawa M; Fujii T; Fujimoto K; Suzuki T
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):523-8. PubMed ID: 7870192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
